57 results
424B5
TCRX
Tscan Therapeutics Inc
17 Apr 24
Prospectus supplement for primary offering
9:58pm
by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. Changes to tax laws (which … to the diligence and reporting requirements in (1) above, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other
8-K
EX-99.1
TCRX
Tscan Therapeutics Inc
17 Apr 24
TScan Therapeutics Announces Launch of $125 million Proposed
6:25am
available, may be obtained from: Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014
8-K
EX-1.1
TCRX
Tscan Therapeutics Inc
17 Apr 24
TScan Therapeutics Announces Launch of $125 million Proposed
6:25am
or enforced by the U.S. Department of the Treasury’s Office of Foreign Assets Control, the United Nations Security Council, the European Union, His
8-K
EX-4.1
pyouzf3epoylpf
17 Apr 24
TScan Therapeutics Announces Launch of $125 million Proposed
6:25am
8-K
EX-99.2
w3a2eexkp hbau2zkxh
17 Apr 24
TScan Therapeutics Announces Launch of $125 million Proposed
6:25am
424B5
0n32iqxllle pueere
16 Apr 24
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.2
uxh jsuncuonerf164v
11 Dec 23
Regulation FD Disclosure
8:00am
8-K
EX-99.1
fieyin
11 Dec 23
Regulation FD Disclosure
8:00am
8-K
EX-99.1
zn5wqjym satcl
9 Nov 23
TScan Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:15am
8-K
EX-4.1
mn2 1d32u
31 May 23
TScan Therapeutics Announces Launch of Proposed Public Offering
8:16am
8-K
EX-1.1
sz4u31 k39
31 May 23
TScan Therapeutics Announces Launch of Proposed Public Offering
8:16am
8-K
EX-99.2
1fff8mq4gs vtbz7i
31 May 23
TScan Therapeutics Announces Launch of Proposed Public Offering
8:16am
8-K
EX-99.1
9hily6ng4eql zrr
31 May 23
TScan Therapeutics Announces Launch of Proposed Public Offering
8:16am